LPTX icon

Leap Therapeutics

78 hedge funds and large institutions have $139M invested in Leap Therapeutics in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 18 closing their positions.

Holders
78
Holders Change
+15
Holders Change %
+23.81%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
33
Increased
19
Reduced
8
Closed
18
Calls
$1.85M
Puts
$492K
Net Calls
+$1.35M
Net Calls Change
+$1.35M
Name Holding Trade Value Shares
Change
Shares
Change %
DM
76
Deerfield Management
New York
-$16M -400,000 Closed
TLP
77
Tri Locum Partners
New York
-$7.26M -181,067 Closed
EI
78
EAM Investors
California
-$3.11M -77,633 Closed
EGI
79
EAM Global Investors
California
-$2.31M -57,561 Closed
OM
80
Opaleye Management
Massachusetts
-$1.91M -47,600 Closed
MS
81
Maven Securities
Jersey
-$1.81M -45,000 Closed
Alyeska Investment Group
82
Alyeska Investment Group
Illinois
-$1.57M -39,260 Closed
VF
83
Virtu Financial
New York
-$1.32M -32,821 Closed
SCM
84
Stonepine Capital Management
Oregon
-$1M -25,000 Closed
Squarepoint
85
Squarepoint
New York
-$323K -8,046 Closed
QP
86
Quilter Plc
United Kingdom
-$281K -7,000 Closed
Barclays
87
Barclays
United Kingdom
-$244K -6,099 Closed
TSS
88
Two Sigma Securities
New York
-$192K -4,778 Closed
SCA
89
Sassicaia Capital Advisers
New York
-$128K -3,200 Closed
PVI
90
Pura Vida Investments
New York
-$100K -2,500 Closed
ECM
91
ExodusPoint Capital Management
New York
-$86K -2,151 Closed
LC
92
Lindbrook Capital
California
-$40K -1,000 Closed
Wells Fargo
93
Wells Fargo
California
-$21K -521 Closed